Skip to search boxSkip to navigationSkip to main content

Mechanism of fluoride-induced MAP kinase activation in pulmonary artery endothelial cells

  • Natalia V. Bogatcheva
    ,
  • Peiyi Wang
    ,
  • Anna A. Birukova
    ,
  • ,
  • Joe G.N. Garcia(corresponding author)
*Corresponding author for this work
  • The University of Chicago
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

In this study, we demonstrate that challenge of endothelial cells (EC) with NaF, a recognized G protein activator and protein phosphatase inhibitor, leads to a significant Erk activation, with increased phosphorylation of the well-known Erk substrate caldesmon. Inhibition of the Erk MAPK, MEK, by U0126 produces a marked decrease in NaF-induced caldesmon phosphorylation. NaF transiently increases the activity of the MEK kinase known as Raf-1 (∼3- to 4-fold increase over basal level), followed by a sustained Raf-1 inhibition (∼3- to 4-fold decrease). Selective Raf-1 inhibitors (ZM-336372 and Raf-1 inhibitor 1) significantly attenuate NaF-induced Erk and caldesmon phosphorylation. Because we have previously shown that Ca2+/ calmodulin-dependent protein kinase II (CaMKII) participates in Erk activation in thrombin-challenged cells, we next explored if CaMKII is involved in NaF-induced EC responses. We found that in NaF-treated EC, CaMKII activity increases in a time-dependent manner with maximal activity at 10 min (∼4-fold increase over a basal level). Pretreatment with KN93, a specific CaMKII inhibitor, attenuates NaF-induced barrier dysfunction and Erk phosphorylation. The Rho inhibitor C3 exotoxin completely abolishes NaF-induced CaMKII activation. Collectively, these data suggest that sequential activation of Raf-1, MEK, and Erk is modulated by Rho-dependent CaMKII activation and represents important NaF-induced signaling response. Caldesmon phosphorylation occurring by an Erk-dependent mechanism in NaF-treated pulmonary EC may represent a link between NaF stimulation and contractile responses of endothelium.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages L1139-L1145

Journal (Volume, Issue Number)

American Journal of Physiology - Lung Cellular and Molecular Physiology (Volume 290, Issue 6)

Publication milestones

  • Published - 06/2006

Publication status

Published - 06/2006

ISSN

1040-0605

Publication IDs

  • Scopus: 33744797358
  • PubMed: 16414982

Publication metrics

Metrics

SciVal
FWCI
0.18
SciVal
Author count
5
SciVal
citations
23
SciVal
Paper percentile
75
Scopus
citations
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Mentions
2
Captures
21
Citation count
30

Funding Details

FunderFunding number
NHLBI
R01HL067307